115 related articles for article (PubMed ID: 37722886)
1. Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention.
Yamamoto K; Morimoto T; Natsuaki M; Shiomi H; Ozasa N; Sakamoto H; Takeji Y; Domei T; Tada T; Taniguchi R; Uegaito T; Yamada M; Takeda T; Eizawa H; Suwa S; Shirotani M; Tamura T; Inoko M; Sakai H; Ishii K; Toyofuku M; Miki S; Onodera T; Furukawa Y; Inada T; Ando K; Kadota K; Nakagawa Y; Kimura T;
Circ J; 2024 May; 88(6):888-899. PubMed ID: 37722886
[TBL] [Abstract][Full Text] [Related]
2. Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-2.
Yamamoto K; Natsuaki M; Yoshikawa Y; Morimoto T; Shiomi H; Watanabe H; Kato T; Saito N; Kadota K; Ando K; Furukawa Y; Tamura T; Sakamoto H; Toyofuku M; Inada T; Inoko M; Suwa S; Onodera T; Ishii K; Kanamori N; Kimura T;
Circ J; 2020 Sep; 84(10):1734-1745. PubMed ID: 32893236
[TBL] [Abstract][Full Text] [Related]
3. Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary Intervention.
Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Ozasa N; Sakamoto H; Takeji Y; Imada K; Tada T; Taniguchi R; Uegaito T; Yamada M; Takeda T; Eizawa H; Suwa S; Shirotani M; Tamura T; Inoko M; Sakai H; Yamamoto T; Ishii K; Takahashi M; Tamura T; Miki S; Onodera T; Furukawa Y; Tanaka M; Ando K; Kadota K; Nakagawa Y; Kimura T;
Am J Cardiol; 2021 Nov; 159():19-29. PubMed ID: 34497005
[TBL] [Abstract][Full Text] [Related]
4. Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
Yamamoto K; Shiomi H; Morimoto T; Takeji Y; Yoshikawa Y; Natsuaki M; Watanabe H; Tada T; Tazaki J; Yamaji K; Tamura T; Ando K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T
Catheter Cardiovasc Interv; 2021 May; 97(6):E758-E770. PubMed ID: 33064372
[TBL] [Abstract][Full Text] [Related]
5. Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan - From the CREDO-Kyoto Registry Cohort-2 and Cohort-3.
Natsuaki M; Morimoto T; Shiomi H; Yamamoto K; Yamaji K; Watanabe H; Uegaito T; Matsuda M; Tamura T; Taniguchi R; Inoko M; Mabuchi H; Takeda T; Domei T; Shirotani M; Ehara N; Eizawa H; Ishii K; Tanaka M; Inada T; Onodera T; Nawada R; Shinoda E; Yamada M; Yamamoto T; Sakai H; Toyofuku M; Tamura T; Takahashi M; Tada T; Sakamoto H; Tada T; Kaneda K; Miki S; Aoyama T; Suwa S; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
Circ J; 2022 Apr; 86(5):748-759. PubMed ID: 34526432
[TBL] [Abstract][Full Text] [Related]
6. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
[TBL] [Abstract][Full Text] [Related]
7. Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation.
Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Yoshikawa Y; Tazaki J; Tada T; Watanabe H; Kato E; Toyofuku M; Inada T; Kaneda K; Takeda T; Sakai H; Yamamoto T; Eizawa H; Yamada M; Shinoda E; Mabuchi H; Shirotani M; Matsuda M; Takahashi M; Ishii K; Onodera T; Sakamoto H; Aoyama T; Miki S; Ando K; Kimura T;
Am J Cardiol; 2022 Jan; 162():13-23. PubMed ID: 34706818
[TBL] [Abstract][Full Text] [Related]
8. A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
Chen Y; Yin T; Xi S; Zhang S; Yan H; Tang Y; Qian J; Chen J; Su X; Du Z; Wang L; Qin Q; Gao C; Zheng Y; Zhao X; Cheng X; Li Z; Zhang W; Chen H; Wang J; Yang Z; Li H; Liu H; Zhou X; Qu B; Xiang D; Guo Y; Wang L; Nie S; Fu G; Yang M; Cai S
Catheter Cardiovasc Interv; 2019 Jun; 93(7):1194-1204. PubMed ID: 31112635
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.
Nakamura M; Kadota K; Takahashi A; Kanda J; Anzai H; Ishii Y; Shibata Y; Yasaka Y; Takamisawa I; Yamaguchi J; Takeda Y; Harada A; Motohashi T; Iijima R; Uemura S; Murakami Y;
J Am Heart Assoc; 2020 May; 9(10):e015439. PubMed ID: 32394794
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
Watanabe H; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Tazaki J; Watanabe H; Natsuaki M; Minatoya K; Hanyu M; Komiya T; Kimura T;
Catheter Cardiovasc Interv; 2020 Jul; 96(1):42-51. PubMed ID: 31389659
[TBL] [Abstract][Full Text] [Related]
11. Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention.
Yamamoto K; Shiomi H; Morimoto T; Natsuaki M; Takeji Y; Watanabe H; Yoshikawa Y; Matsumura-Nakano Y; Shizuta S; Tanabe K; Ando K; Kadota K; Morino Y; Kozuma K; Nakagawa Y; Kimura T
Am J Cardiol; 2020 Feb; 125(3):399-408. PubMed ID: 31771755
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3).
Yamamoto K; Shiomi H; Morimoto T; Kadota K; Tada T; Takeji Y; Matsumura-Nakano Y; Yoshikawa Y; Imada K; Domei T; Kaneda K; Taniguchi R; Ehara N; Nawada R; Natsuaki M; Yamaji K; Toyofuku M; Kanemitsu N; Shinoda E; Suwa S; Iwakura A; Tamura T; Soga Y; Inada T; Matsuda M; Koyama T; Aoyama T; Sato Y; Furukawa Y; Ando K; Yamazaki F; Komiya T; Minatoya K; Nakagawa Y; Kimura T;
Am J Cardiol; 2021 Apr; 145():47-57. PubMed ID: 33454345
[TBL] [Abstract][Full Text] [Related]
13. Transradial versus transfemoral approach in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction: insight from the CREDO-Kyoto AMI registry.
Yamashita Y; Shiomi H; Morimoto T; Yaku H; Kaji S; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Abe M; Akao M; Nagao K; Shizuta S; Ono K; Kimura T;
Heart Vessels; 2017 Dec; 32(12):1448-1457. PubMed ID: 28698995
[TBL] [Abstract][Full Text] [Related]
14. Five-year outcomes of percutaneous versus surgical coronary revascularization in patients with diabetes mellitus (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2015 Apr; 115(8):1063-72. PubMed ID: 25733384
[TBL] [Abstract][Full Text] [Related]
15. Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.
Tokushige A; Shiomi H; Morimoto T; Ono K; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Shizuta S; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Hamasaki S; Ohishi M; Nakashima H; Mitsudo K; Nobuyoshi M; Kita T; Imoto Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
Circ Cardiovasc Interv; 2014 Aug; 7(4):482-91. PubMed ID: 25074253
[TBL] [Abstract][Full Text] [Related]
16. Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria.
Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Watanabe H; Yamaji K; Watanabe H; Kato T; Saito N; Ando K; Kadota K; Furukawa Y; Kimura T;
Circ J; 2020 Apr; 84(5):723-732. PubMed ID: 32188831
[TBL] [Abstract][Full Text] [Related]
17. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
Baber U; Li SX; Pinnelas R; Pocock SJ; Krucoff MW; Ariti C; Gibson CM; Steg PG; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Iakovou I; Dangas G; Aquino MB; Sartori S; Chieffo A; Moliterno DJ; Colombo A; Mehran R
Circ Cardiovasc Interv; 2018 Mar; 11(3):e006144. PubMed ID: 29870385
[TBL] [Abstract][Full Text] [Related]
19. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
[TBL] [Abstract][Full Text] [Related]
20. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.
Natsuaki M; Morimoto T; Watanabe H; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Hanaoka KI; Kozuma K; Tanabe K; Morino Y; Muramatsu T; Kimura T;
J Am Heart Assoc; 2019 Nov; 8(22):e013356. PubMed ID: 31701821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
